Mitoxantrone Hydrochloride Liposome Injection

mitoxantrone hydrochloride liposome · CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.

Drug timelines are a Plus or Pro feature.

12 regulatory and trial events tracked for Mitoxantrone Hydrochloride Liposome Injection, covering 2014-01-23 to 2025-07-17. Get the full timeline:

Most recent: Clinical Trial Update: Mitoxantrone Hydrochloride Liposome Injection-containing Bridging Regimen and CD19-targeting CAR-T Therapies [Phase 2]

See pricing